酒渣鼻的综合医学管理：中期研究报告及文献综述
Comprehensive medical management of rosacea: an interim study report and literature review.
作者信息
Del Rosso James Q, Baum Eric W
出版信息
J Clin Aesthet Dermatol. 2008 May;1(1):20-5.
Abstract
Rosacea is a common inflammatory facial dermatosis seen in adults that exhibits considerable variety in clinical presentation. Multiple medical therapeutic options are available including topical and oral treatments. Optimal medical management of rosacea includes assessment of subtype and disease severity and use of appropriate skin care to reduce epidermal barrier dysfunction. This article provides an overall discussion of the medical management of rosacea and reviews interim results from a study evaluating the role of designated skin care in rosacea treatment.
摘要
酒渣鼻是一种常见于成人的炎症性面部皮肤病，临床表现具有很大的多样性。有多种医学治疗选择，包括局部和口服治疗。酒渣鼻的最佳医学管理包括评估亚型和疾病严重程度，以及使用适当的皮肤护理来减少表皮屏障功能障碍。本文全面讨论了酒渣鼻的医学管理，并综述了一项评估特定皮肤护理在酒渣鼻治疗中作用的研究的中期结果。
相似文献
1
Comprehensive medical management of rosacea: an interim study report and literature review.
J Clin Aesthet Dermatol. 2008 May;1(1):20-5.
2
Facial hygiene and comprehensive management of rosacea.
Cutis. 2004 Mar;73(3):183-7.
3
Current topical and systemic approaches to treatment of rosacea.
J Eur Acad Dermatol Venereol. 2009 Aug;23(8):876-82. doi: 10.1111/j.1468-3083.2009.03167.x.
4
Medical treatment of rosacea with emphasis on topical therapies.
Expert Opin Pharmacother. 2004 Jan;5(1):5-13. doi: 10.1517/14656566.5.1.5.
5
Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS).
J Clin Aesthet Dermatol. 2019 Jun;12(6):17-24. Epub 2019 Jun 1.
6
Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS).
J Clin Aesthet Dermatol. 2020 Jun;13(6 Suppl):S17-S24. Epub 2020 Jun 1.
7
Diagnosis and treatment of rosacea.
J Am Board Fam Pract. 2002 May-Jun;15(3):214-7.
8
Rosacea Management: Update on general measures and topical treatment options.
J Dtsch Dermatol Ges. 2016 Dec;14 Suppl 6:17-27. doi: 10.1111/ddg.13143.
9
Skin compatibility and efficacy of a cosmetic skin care regimen with licochalcone A and 4-t-butylcyclohexanol in patients with rosacea subtype I.
J Eur Acad Dermatol Venereol. 2016 Feb;30 Suppl 1:21-7. doi: 10.1111/jdv.13531.
10
Standard management options for rosacea, part 2: options according to subtype.
Cutis. 2009 Aug;84(2):97-104.
引用本文的文献
1
Skin 101: Understanding the Fundamentals of Skin Barrier Physiology-Why is This Important for Clinicians?
J Clin Aesthet Dermatol. 2025 Feb;18(2):7-15.
2
Demographic and clinical features of rosacea in North Jordan: a 10-year university hospital retrospective study.
Ann Med. 2025 Dec;57(1):2445775. doi: 10.1080/07853890.2024.2445775. Epub 2024 Dec 26.
3
Rosacea: Practical Guidance and Challenges for Clinical Management.
Clin Cosmet Investig Dermatol. 2024 Jan 23;17:175-190. doi: 10.2147/CCID.S391705. eCollection 2024.
4
Rosacea pathogenesis and therapeutics: current treatments and a look at future targets.
Front Med (Lausanne). 2023 Dec 13;10:1292722. doi: 10.3389/fmed.2023.1292722. eCollection 2023.
5
Treatment options and emotional well-being in patients with rosacea: An unsupervised machine learning analysis of over 200,000 posts.
JAAD Int. 2023 Jul 30;13:172-178. doi: 10.1016/j.jdin.2023.07.012. eCollection 2023 Dec.
6
Development and Optimization of a Novel Lozenge Containing a Metronidazole-Peppermint Oil-Tranexamic Acid Self-Nanoemulsified Delivery System to Be Used after Dental Extraction: In Vitro Evaluation and In Vivo Appraisal.
Pharmaceutics. 2023 Sep 19;15(9):2342. doi: 10.3390/pharmaceutics15092342.
7
Increased Prevalence of Face Mask-Induced Itch in Health Care Workers.
Biology (Basel). 2020 Dec 7;9(12):451. doi: 10.3390/biology9120451.
8
Azelaic Acid Topical Formulations: Differentiation of 15% Gel and 15% Foam.
J Clin Aesthet Dermatol. 2017 Mar;10(3):37-40. Epub 2017 Mar 1.
9
Anti-inflammatory and Immunomodulatory Effects of Antibiotics and Their Use in Dermatology.
Indian J Dermatol. 2016 Sep-Oct;61(5):469-81. doi: 10.4103/0019-5154.190105.
10
Advances in understanding and managing rosacea: part 2: the central role, evaluation, and medical management of diffuse and persistent facial erythema of rosacea.
J Clin Aesthet Dermatol. 2012 Mar;5(3):26-36.
本文引用的文献
1
Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea.
Nat Med. 2007 Aug;13(8):975-80. doi: 10.1038/nm1616. Epub 2007 Aug 5.
2
Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea.
J Am Acad Dermatol. 2007 May;56(5):791-802. doi: 10.1016/j.jaad.2006.11.021. Epub 2007 Mar 23.
3
An evaluation of a polyhydroxy acid skin care regimen in combination with azelaic acid 15% gel in rosacea patients.
J Cosmet Dermatol. 2006 Mar;5(1):23-9. doi: 10.1111/j.1473-2165.2006.00219.x.
4
Update on rosacea pathogenesis and correlation with medical therapeutic agents.
Cutis. 2006 Aug;78(2):97-100.
5
The effect of Cetaphil Gentle Skin Cleanser on the skin barrier of patients with rosacea.
Cutis. 2006 Apr;77(4 Suppl):27-33.
6
A clinical overview of azelaic acid.
Cutis. 2006 Feb;77(2 Suppl):12-6.
7
The rationale for advancing the formulation of azelaic acid vehicles.
Cutis. 2006 Feb;77(2 Suppl):7-11.
8
Adjunctive skin care in the management of rosacea: cleansers, moisturizers, and photoprotectants.
Cutis. 2005 Mar;75(3 Suppl):17-21; discussion 33-6.
9
Treating beyond the histology of rosacea.
Cutis. 2004 Sep;74(3 Suppl):28-31, 32-4.
10
Ultraviolet light and rosacea.
Cutis. 2004 Sep;74(3 Suppl):13-6, 32-4.
Zotero 插件